GlassScriptPhysician profile
Jason Maljaars
NPI 1124540661
$825.88
in general payments reported to CMS, 2019-2025
13 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.49 · 2023: $283 · 2024: $316 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $205.34 | 2023-2025 | Jot Dx |
| Boston Scientific Corporation | $152.47 | 2023-2024 | Watchman Access System |
| Ceribell, INC. | $117.16 | 2025 | Pocket Eeg Device |
| Ucb, INC. | $77.07 | 2022-2023 | Briviact |
| Alexion Pharmaceuticals, INC. | $61.22 | 2023-2024 | Ultomiris |
| Pfizer INC. | $55.42 | 2024 | |
| Janssen Pharmaceuticals, INC | $40.08 | 2023 | Xarelto |
| Livanova USA, INC. | $31.09 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Astrazeneca Pharmaceuticals LP | $24.43 | 2023 | Andexxa |
| Genentech USA, INC. | $16.99 | 2023 | |
| Lilly USA, LLC | $16.46 | 2024 | Amyvid |
| Merz Pharmaceuticals, LLC | $15.73 | 2025 | Xeomin |
| Eisai INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Maljaars listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.